The subject technology relates to the delivery of implantable medical devices and systems for delivering implantable medical devices.
The use of endovascular techniques for the implantation of medical devices for treatment, e.g., by occlusion, of body cavities such as arteries, veins, fallopian tubes or vascular deformities is known in the art. For example, vascular aneurysms can be occluded with an implant that is introduced with a delivery wire through a catheter. Once advanced to the treatment site, the implant is inserted into the aneurysm cavity to occlude the aneurysm and then detached from the delivery wire.
Electrolytic detachment of an implant from a delivery system can leave a portion of a delivery wire protruding from the implant after detachment, presenting a risk of harm to the surrounding anatomy. An implant can be attached to a delivery wire in a manner that minimizes an extent to which a distal region of the delivery wire protrudes from the implant after the implant is detached from a proximal region of the delivery wire. For example, an implant can be connected to a distal end of a delivery wire such that a severed distal portion of the delivery wire is retracted into an interior space of the implant upon severance of the implant from the proximal region of the delivery wire. Such an arrangement advantageously can reduce the extent of protrusion compared to an attachment that does not provide retraction capability.
The subject technology is illustrated, for example, according to various aspects described below. Various examples of aspects of the subject technology are described as numbered clauses (1, 2, 3, etc.) for convenience. These are provided as examples and do not limit the subject technology.
Clause 1. An implant comprising:
Clause 2. The implant of clause 1, wherein the expansion member comprises a spring.
Clause 3. The implant of any of the previous clauses, wherein a distal cross-sectional dimension of the distal region is greater than a lumen cross-sectional dimension of the lumen.
Clause 4. The implant of any of the previous clauses, wherein the distal region of the delivery wire comprises an electrolytically corrodible section.
Clause 5. The implant of any of the previous clauses, wherein the delivery wire comprises a detachment zone proximal to the proximal end portion.
Clause 6. The implant of clause 5, wherein a distal cross-sectional dimension of the distal region is greater than a proximal cross-sectional dimension of the detachment zone.
Clause 7. The implant of clause 5, further comprising a coating layer that electrically insulates the detachment zone of the delivery wire from the proximal end portion.
Clause8. A delivery system comprising:
Clause 9. The implant of clause 8, wherein the expansion member comprises a spring.
Clause 10. The implant of any of clauses 8-9, wherein the proximal end portion defines a lumen, and at least a portion of the delivery wire extends entirely through the lumen.
Clause 11. The implant of any of clauses 8-10, wherein a distal cross-sectional dimension of the distal region is greater than a lumen cross-sectional dimension of the lumen.
Clause 12. The implant of any of clauses 8-11, wherein the distal region of the delivery wire comprises an electrolytically corrodible section.
Clause 13. The implant of an of clauses 8-12, wherein a distal cross-sectional dimension of the distal region is greater than a proximal cross-sectional dimension of the detachment zone.
Clause 14. The implant of any of clauses 8-13, further comprising a coating layer that electrically insulates the detachment zone of the delivery wire from the proximal end portion.
Clause 15. A method of delivering an implant, the method comprising:
Clause 16. The method of clause 15, wherein separating the implant comprises electrolytically corroding a portion of the delivery wire.
Clause 17. The method of an of clauses 15-16, wherein positioning the implant comprises applying a distally directed force to the proximal end portion and a proximally directed force to the delivery wire.
Clause 18. The method of any of clauses 15-17, wherein applying a distally directed force to the proximal end portion comprises pushing the proximal end portion with a catheter.
Clause 19. The method of any of clauses 15-18, wherein at least a portion of the delivery wire is within the catheter during the separating.
Clause 20. The method of any of clauses 15-19, wherein the advancing the distal region comprises advancing the detachment zone and the distal region of the delivery wire to be entirely distal to a proximal end of the proximal end portion.
Additional features and advantages of the subject technology will be set forth in the description below, and in part will be apparent from the description, or may be learned by practice of the subject technology. The advantages of the subject technology will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.
It is to be understood that both the foregoing general description and the following detailed description are exemplifying and explanatory and are intended to provide further explanation of the subject technology as claimed.
The accompanying drawings, which are included to provide further understanding of the subject technology and are incorporated in and constitute a part of this description, illustrate aspects of the subject technology and, together with the specification, serve to explain principles of the subject technology.
In the following detailed description, specific details are set forth to provide an understanding of the subject technology. It will be apparent, however, to one ordinarily skilled in the art that the subject technology may be practiced without some of these specific details. In other instances, well-known structures and techniques have not been shown in detail so as not to obscure the subject technology.
In accordance with some embodiments of the subject technology an implant can be attached to a delivery wire in a manner that minimizes an extent to which a distal region of the delivery wire protrudes from the implant after the implant is detached from a proximal region of the delivery wire. For example, an implant can be connected to a distal end of a delivery wire such that a severed distal region of the delivery wire is retracted into an interior space of the implant upon severance of the implant from the proximal region of the delivery wire. Such an arrangement advantageously can reduce the extent of protrusion compared to an attachment that does not provide retraction capability.
Referring to
According to some embodiments, for example as shown in
A power supply 46 can be coupled to the delivery system 10. A current can flow from the power supply 46 along a delivery wire 44 to a detachment zone 30. The detachment zone 30 can comprise a longitudinally extending zone within which some or all of an electrolytically corrodible portion of the delivery wire 44 can be positioned, as discussed further herein. The detachment zone 30 can be between a portion of the delivery wire 44 and the implant 20. The current can flow from the detachment zone 30 to a return path, optionally via a structure extending near the detachment zone 30. For example, the power supply 46 can be coupled to a portion of the delivery wire 44 extending proximally of the handle 48, and the delivery wire 44 can conduct the electrically current to or from the detachment zone 30. Alternatively or in combination, the power supply 46 also can be coupled to, and electrical current can be conducted by, the delivery wire 44, the handle 48, the delivery catheter 100, the fluid source 150, and/or the patient via a region 47 on the surface of the patient's skin to provide a conductive pathway between the detachment zone 30 and the power supply 46 or ground. For example, a positive terminal of a direct current power supply 46, for example as shown in
According to some embodiments, the power supply 46 can include an electrical generator configured to output an electrical current that is sufficient to detach the implant 20 by electrolytic corrosion. The power supply 46 may be a direct current power supply, an alternating current power supply, or a power supply switchable between a direct current and an alternating current. The power supply 46 can include a suitable controller that can be used to control various parameters of the energy output by the generator, such as intensity, amplitude, duration, frequency, duty cycle, and polarity. For example, the power supply 46 can provide a voltage of about 12 volts to about 28 volts and a current of about 1 mA to about 2 mA.
According to some embodiments, for example as shown in
According to some embodiments, for example as shown in
According to some embodiments, the implant 20 can be placed within an aneurysm 2 at a vascular bifurcation 4, formed by trunk vessel 6 and branch vessels 8, for example as illustrated in
While the implant 20 illustrated herein is a braided ball, the implant 20 can be any well-known treatment device including, but not limited to, a vasoocclusive coil, a stents, filters, or flow diverters.
According to some embodiments, for example as shown in
According to some embodiments, portions of the delivery wire 44 can be coated with a nonconductive material so that only a limited portion of surface area of the delivery wire is exposed to, and in electrical communication with, the electrolyte for corrosion when a voltage potential is applied. Limiting the size of the exposed portion of the surface area of the delivery wire can concentrate electrolytic activity to expedite corrosion through and severance of the delivery wire. A proximal insulating layer 34 can be provided over at least a portion of an outer surface of the proximal region 40. For example, the proximal insulating layer 34 can circumferentially surround an outer surface of the proximal region 40 extending proximally from a proximal end of the detachment zone 30 to a location at or near a proximal end of the delivery wire 44. Similarly, a distal insulating layer 32 can be provided over at least a portion of an outer surface of the distal region 42 extending distally from a distal end of the detachment zone 30 to a distal terminal end of the delivery wire 44. For example, the distal insulating layer 32 can circumferentially surround and cover the entire outer surface of the distal region 42.
According to some embodiments, proximal and distal insulating layers 34, 32 leave exposed the detachment zone 30 between the proximal region 40 and the distal region 42. When in contact with a body fluid, such as blood, the fluid serves as an electrolyte allowing current to be focused on the non-coated detachment zone 30. The proximal and distal insulating layers 34, 32 prevent exposure of the proximal region 40 and the distal region 42 to the fluid. Accordingly, electrical energy conducted along the delivery wire 44 is concentrated at the detachment zone 30, thereby reducing the time required to erode away the detachment zone 30. The proximal and distal insulating layers 34, 32 can be over-molded, co-extruded, sprayed on, or dip-coated with respect to the proximal region 40 and/or the distal region 42.
The distal insulating layer 32 also prevents electrical connection between the delivery wire 44 and the implant 20. As shown in
The proximal and distal insulating layers 34, 32 can be of an electrically nonconductive or insulative polymer, such as polyimide, polypropylene, polyolefins, and combinations thereof. In some embodiments, the proximal and distal insulating layers 34, 32 can be applied as a single coating with a portion thereof subsequently removed to expose the detachment zone 30. Laser ablation can be employed to selectively remove the coating to a controlled length, minimizing the time required to erode through the component. Lengths as small as 0.0005″ and as large as 0.1″ or longer can be removed. According to some embodiments, lengths of detachment zone 30 can be greater than 0.005″ and/or less than 0.010″ to provide sufficient exposure to achieve detachment times of less than 30 seconds.
The delivery wire 44 (including some or all of the proximal region 40, the distal region 42, or the detachment region 30) can comprise one or more of the following materials: ceramic materials, plastics, base metals or alloys thereof, or combinations thereof. Some of the most suitable material combinations for forming the electrolytically corrodible points can include one or more of the following: stainless steels, preferably of the type AISI 301, 304, 316, or subgroups thereof; Ti or TiNi alloys; Co-based alloys; noble metals; or noble metal alloys, such as Pt, Pt metals, Pt alloys, Au alloys, or Sn alloys. In some embodiments, the electrolytically corrodible detachment zone 30 can be pre-corroded by etching or other methods.
According to some embodiments, for example as shown in
According to some embodiments, for example as shown in
According to some embodiments, a distal section 80 of the distal region 42 can be located distal to the hub 50 the distal section 80 can have a distal outer cross-sectional dimension 82 that is greater than the proximal outer cross-sectional dimension 72 and/or the inner cross-sectional dimension 54 of the lumen 52. The dimensions of the distal section 80 can prevent the distal section 80 and other sections attached thereto from moving entirely through the lumen 52 of the hub 50. Furthermore, the distal outer cross-sectional dimension 82 can be greater than any opening, aperture, interstice, port, or window separating the inner cavity 90 of the implant 20 from an external environment. Accordingly, once the implant 20 is fully formed, the distal section 80 and any components attached thereto can be prevented from moving entirely out of the inner cavity 90 of the implant 20.
According to some embodiments, an expansion member 60, or a portion thereof, can be located between at least a portion of the distal section 80 and at least a portion of the hub 50. The expansion member 60 can be or include a spring or other mechanism for providing elastic forces. For example, the spring can be a compression spring that responds to a compression load by shortening or reducing its length. The expansion member 60 can include a helical coil that has a spring constant. Alternatively or in combination, the expansion member 60 can be an axially and/or circumferentially continuous material (e.g., tube, strut, braid, etc.) with elastic properties. The expansion member 60 can store potential energy when placed in certain configurations to provide a bias toward a relaxed state. The bias may include a tendency to axially elongate after the expansion member 60 is axially compressed. Accordingly, the extension member 60 can be biased to move axially adjacent structures axially away from each other. For example, the expansion member 60 can be seated against and/or placed between the hub 50 and the distal section 80. The expansion member 60 can be axially compressed by moving the distal section 80 and the hub 50 toward each other. For example, the distal section 80 can be moved proximally relative to the hub 50 and/or the hub 50 can be move distally relative to the distal section 80. Axial forces can be applied to the distal section 80 by, for example, other portions of the delivery wire 44, such as the proximal region 40 of the delivery wire 44. Axial forces can be applied to the hub 50 by, for example, other devices, such as the delivery catheter 100, as discussed further herein.
According to some embodiments, for example as shown in
According to some embodiments, after separation at the detachment zone 30, the expansion member 60 can act on the hub 50 and the distal section 80 to achieve distally directed movement of the distal section 80 and/or the proximal section 70. After separation, the expansion member 60 can be permitted to freely expand to achieve a relaxed state. The distally directed movement of the distal section 80 and/or the proximal section 70 can continue until a proximalmost terminal end of the proximal section 70 is distal to a proximal most terminal end of the hub 50 and/or the lumen 52. The distally directed movement of the distal section 80 and/or the proximal section 70 can continue until a proximalmost terminal end of the proximal section 70 is entirely distal to the hub 50 and/or within the interior cavity 90 of the implant 20. According to some embodiments, the proximal section 70 and the distal section 80 can freely move within the cavity 90 of the implant 20 after separation. The dimensions of the distal section 80 and/or the proximal section 70 can exceed the dimensions of the lumen 52 and/or other openings between the cavity 90 in an external environment of the implant 20, such that the distal section 80 and the proximal section 70 are retained within the interior cavity 90 of the implant 20.
According to some embodiments, for example as shown in
According to some embodiments, the proximal section 70 can connect to one or more expansion members 160, or a portion thereof, can be located between at least a portion of the distal section 80 and at least a portion of the hub 50. The expansion member 160 can be or include a spring or other mechanism for providing elastic forces. For example, the spring can be a tension or extension spring that responds to a tension load by elongating or increasing its length. The expansion members 160 can include a helical coil that has a spring constant. Alternatively or in combination, the expansion member 160 can be an axially and/or circumferentially continuous material (e.g., tube, strut, braid, etc.) with elastic properties. A plurality of expansion members 160 can attach to various regions or the same region of the proximal section 70 and to various regions or the same region of the hub 50. For example, the expansion members 160 can attach to a distalmost terminal end region of the proximal section 70. The expansion members 160 can attach, for example, to the distal insulating layer 32, such that the distal region 42 is not in electrical connection with the expansion members 160. The expansion members 160 can further attached to a distalmost end region of the hub 50. The expansion members 160 can attach to the hub 50 at a variety of distributed locations along the circumference of the hub 50. According to some embodiments, for example as shown in
The expansion member 160 can store potential energy when placed in certain configurations to provide a bias toward a relaxed state. The bias may include a tendency to axially shorten after the expansion members 160 are axially elongated. Accordingly, the expansion members 160 can be biased to move axially adjacent structures toward each other. For example, the expansion member 160 can be attached to the hub 50 and the proximal section 70. The expansion member 160 can be axially elongated by moving the proximal section 70 and the hub 50 away from each other. For example, the proximal section 70 can be moved proximally relative to the hub 50 and/or the hub 50 can be move distally relative to the proximal section 70. Axial forces can be applied to the proximal section 70 by, for example, other portions of the delivery wire 44, such as the proximal region 40 of the delivery wire 44. Axial forces can be applied to the hub 50 by, for example, other devices, such as the delivery catheter 100, as discussed further herein.
According to some embodiments, for example as shown in
According to some embodiments, the implant 20 can be advanced to the target site. As shown in
According to some embodiments, for example as shown in
According to some embodiments, severance of the detachment zone 30 can be achieved by a variety of mechanisms. Separation along the detachment zone 30 can be achieved by electrolytic corrosion, mechanical release, chemical reactions, thermal activity, or combinations thereof. By any means, the result of the separation can include the complete separation of the implant 20 from at least a portion of the delivery wire 44.
According to some embodiments, for example as shown in
Upon detachment, the delivery wire 44 and the delivery catheter 100 can be retracted away from the target site and out of the patient, leaving the implant 20 at the target site.
The foregoing description is provided to enable a person skilled in the art to practice the various configurations described herein. While the subject technology has been particularly described with reference to the various figures and configurations, it should be understood that these are for illustration purposes only and should not be taken as limiting the scope of the subject technology.
There may be many other ways to implement the subject technology. Various functions and elements described herein may be partitioned differently from those shown without departing from the scope of the subject technology. Various modifications to these configurations will be readily apparent to those skilled in the art, and generic principles defined herein may be applied to other configurations. Thus, many changes and modifications may be made to the subject technology, by one having ordinary skill in the art, without departing from the scope of the subject technology.
A phrase such as “an aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples of the disclosure. A phrase such as “an aspect” may refer to one or more aspects and vice versa. A phrase such as “an embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. A disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments. An embodiment may provide one or more examples of the disclosure. A phrase such “an embodiment” may refer to one or more embodiments and vice versa. A phrase such as “a configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology. A disclosure relating to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples of the disclosure. A phrase such as “a configuration” may refer to one or more configurations and vice versa.
It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplifying approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.
Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.
A reference to an element in the singular is not intended to mean “one and only one” unless specifically stated, but rather “one or more.” The term “some” refers to one or more. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and intended to be encompassed by the subject technology. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the above description.
While certain aspects and embodiments of the subject technology have been described, these have been presented by way of example only, and are not intended to limit the scope of the subject technology. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms without departing from the spirit thereof. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope and spirit of the subject technology.
This application claims the benefit of priority of U.S. Provisional Patent Application No. 62/354,968 filed Jun. 27, 2016, which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
5108407 | Geremia et al. | Apr 1992 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5250071 | Palermo | Oct 1993 | A |
5354295 | Guglielmi et al. | Oct 1994 | A |
5370653 | Cragg | Dec 1994 | A |
5423829 | Pham et al. | Jun 1995 | A |
5509411 | Littmann et al. | Apr 1996 | A |
5522836 | Palermo | Jun 1996 | A |
5540680 | Guqlielmi et al. | Jul 1996 | A |
5624449 | Pham et al. | Apr 1997 | A |
5658308 | Snyder | Aug 1997 | A |
5669931 | Kupiecki et al. | Sep 1997 | A |
5690667 | Gia | Nov 1997 | A |
5733329 | Wallace et al. | Mar 1998 | A |
5743905 | Eder et al. | Apr 1998 | A |
5749894 | Engelson | May 1998 | A |
5766629 | Cho et al. | Jun 1998 | A |
5800455 | Palermo et al. | Sep 1998 | A |
5851206 | Guglielmi et al. | Dec 1998 | A |
5853418 | Ken et al. | Dec 1998 | A |
5855578 | Guglielmi et al. | Jan 1999 | A |
5891128 | Gia et al. | Apr 1999 | A |
5895385 | Guqlielmi et al. | Apr 1999 | A |
5910154 | Tsugita | Jun 1999 | A |
5916235 | Guglielmi | Jun 1999 | A |
5919187 | Guqlielmi et al. | Jul 1999 | A |
5925037 | Guglielmi et al. | Jul 1999 | A |
5925059 | Palermo et al. | Jul 1999 | A |
5928226 | Guqlielmi et al. | Jul 1999 | A |
5935145 | Villar et al. | Aug 1999 | A |
5941888 | Wallace et al. | Aug 1999 | A |
5944114 | Guglielmi et al. | Aug 1999 | A |
5947962 | Guglielmi et al. | Sep 1999 | A |
5947963 | Guqlielmi | Sep 1999 | A |
5951599 | McCrory | Sep 1999 | A |
5964797 | Ho | Oct 1999 | A |
5976126 | Guglielmi | Nov 1999 | A |
5984929 | Bashiri et al. | Nov 1999 | A |
6010498 | Guqlielmi | Jan 2000 | A |
6013084 | Ken et al. | Jan 2000 | A |
6059779 | Mills | May 2000 | A |
6063070 | Eder | May 2000 | A |
6063104 | Villar et al. | May 2000 | A |
6066133 | Guglielmi et al. | May 2000 | A |
6077260 | Wheelock et al. | Jun 2000 | A |
6083220 | Guglielmi et al. | Jul 2000 | A |
6123714 | Gia et al. | Sep 2000 | A |
6136015 | Kurz et al. | Oct 2000 | A |
6146373 | Cragg et al. | Nov 2000 | A |
6156061 | Wallace et al. | Dec 2000 | A |
6165178 | Bashiri et al. | Dec 2000 | A |
6168592 | Kupiecki et al. | Jan 2001 | B1 |
6168615 | Ken et al. | Jan 2001 | B1 |
6168618 | Frantzen | Jan 2001 | B1 |
6193728 | Ken et al. | Feb 2001 | B1 |
6238403 | Greene, Jr. et al. | May 2001 | B1 |
6241691 | Ferrera et al. | Jun 2001 | B1 |
6280457 | Wallace et al. | Aug 2001 | B1 |
6296622 | Kurz et al. | Oct 2001 | B1 |
6299619 | Greene, Jr. et al. | Oct 2001 | B1 |
6306153 | Kurz et al. | Oct 2001 | B1 |
6309367 | Boock | Oct 2001 | B1 |
6371972 | Wallace et al. | Apr 2002 | B1 |
6409721 | Wheelock et al. | Jun 2002 | B1 |
6416373 | Kolb et al. | Jul 2002 | B1 |
6425893 | GuQlielmi | Jul 2002 | B1 |
6425914 | Wallace et al. | Jul 2002 | B1 |
6468266 | Bashiri et al. | Oct 2002 | B1 |
6468301 | Amplatz et al. | Oct 2002 | B1 |
6478773 | Gandhi et al. | Nov 2002 | B1 |
6485524 | Strecker | Nov 2002 | B2 |
6486266 | Amano et al. | Nov 2002 | B2 |
6511468 | Craaa et al. | Jan 2003 | B1 |
6533801 | Wallace et al. | Mar 2003 | B2 |
6558367 | Craaa et al. | May 2003 | B1 |
6589230 | Gia et al. | Jul 2003 | B2 |
6589236 | Wheelock et al. | Jul 2003 | B2 |
6602261 | Greene, Jr. et al. | Aug 2003 | B2 |
6605101 | Schaefer et al. | Aug 2003 | B1 |
6620152 | Guqlielmi | Sep 2003 | B2 |
6623493 | Wallace et al. | Sep 2003 | B2 |
6723112 | Ho et al. | Apr 2004 | B2 |
6743251 | Eder | Jun 2004 | B1 |
6835185 | Ramzipoor et al. | Dec 2004 | B2 |
6878384 | Cruise et al. | Apr 2005 | B2 |
6905503 | Gifford, III et al. | Jun 2005 | B2 |
6936055 | Ken et al. | Aug 2005 | B1 |
6953473 | Porter | Oct 2005 | B2 |
6964657 | Craaa et al. | Nov 2005 | B2 |
6966892 | Gandhi et al. | Nov 2005 | B2 |
7014645 | Greene, Jr. et al. | Mar 2006 | B2 |
7083567 | Mawad | Aug 2006 | B2 |
7094249 | Broome | Aug 2006 | B1 |
7128736 | Abrams et al. | Oct 2006 | B1 |
7166122 | Aqanon et al. | Jan 2007 | B2 |
7169172 | Levine et al. | Jan 2007 | B2 |
7198613 | Gandhi et al. | Apr 2007 | B2 |
7229461 | Chin et al. | Jun 2007 | B2 |
7238194 | Monstadt et al. | Jul 2007 | B2 |
7255707 | Ramzipoor et al. | Aug 2007 | B2 |
7300458 | Henkes et al. | Nov 2007 | B2 |
7323000 | Monstdt et al. | Jan 2008 | B2 |
7331974 | Schaefer et al. | Feb 2008 | B2 |
7485122 | Teoh | Feb 2009 | B2 |
7524322 | Monstdt et al. | Apr 2009 | B2 |
7601160 | Richter | Oct 2009 | B2 |
7608089 | Wallace et al. | Oct 2009 | B2 |
RE41029 | Guglielmi et al. | Dec 2009 | E |
7651513 | Teoh et al. | Jan 2010 | B2 |
7695484 | Wallace et al. | Apr 2010 | B2 |
7879064 | Monstadt et al. | Feb 2011 | B2 |
7896899 | Patterson et al. | Mar 2011 | B2 |
7938845 | Aganon et al. | May 2011 | B2 |
RE42625 | Guglielmi | Aug 2011 | E |
8002789 | Ramzipoor et al. | Aug 2011 | B2 |
RE42756 | Guqlielmi et al. | Sep 2011 | E |
8016869 | Nikolchev | Sep 2011 | B2 |
8021416 | Abrams | Sep 2011 | B2 |
8043326 | Hancock et al. | Oct 2011 | B2 |
8048104 | Monstadt et al. | Nov 2011 | B2 |
RE43311 | Wallace et al. | Apr 2012 | E |
8157855 | Eidenschink et al. | Apr 2012 | B2 |
8202292 | Kellett | Jun 2012 | B2 |
8221396 | Dehnad et al. | Jul 2012 | B2 |
8221483 | Ford et al. | Jul 2012 | B2 |
8273116 | Licata et al. | Sep 2012 | B2 |
8298256 | Gandhi et al. | Oct 2012 | B2 |
8328860 | Strauss et al. | Dec 2012 | B2 |
8372110 | Monstadt et al. | Feb 2013 | B2 |
8398671 | Chen et al. | Mar 2013 | B2 |
8425541 | Masters et al. | Apr 2013 | B2 |
8470013 | Duggal et al. | Jun 2013 | B2 |
8480701 | Monstadt | Jul 2013 | B2 |
8562667 | Cox | Oct 2013 | B2 |
8597321 | Monstadt et al. | Dec 2013 | B2 |
8632584 | Henkes et al. | Jan 2014 | B2 |
8641746 | Andreas et al. | Feb 2014 | B2 |
8641777 | Strauss et al. | Feb 2014 | B2 |
8652163 | Padilla et al. | Feb 2014 | B2 |
8657870 | Turovskiv et al. | Feb 2014 | B2 |
8715312 | Burke et al. | May 2014 | B2 |
8715317 | Janardhan et al. | May 2014 | B1 |
8721625 | Klint | May 2014 | B2 |
8728142 | Gandhi et al. | May 2014 | B2 |
8777978 | Strauss et al. | Jul 2014 | B2 |
8777979 | Shrivastava et al. | Jul 2014 | B2 |
8795320 | Strauss et al. | Aug 2014 | B2 |
8795321 | Strauss et al. | Aug 2014 | B2 |
8801747 | Strauss et al. | Aug 2014 | B2 |
8845676 | Monstadt et al. | Sep 2014 | B2 |
8864790 | Strauss et al. | Oct 2014 | B2 |
8870909 | Cox | Oct 2014 | B2 |
8876863 | Eskridqe | Nov 2014 | B2 |
8900285 | Licata | Dec 2014 | B2 |
8906057 | Connor et al. | Dec 2014 | B2 |
8915950 | Cam et al. | Dec 2014 | B2 |
8926681 | Levv et al. | Jan 2015 | B2 |
8932317 | Marks et al. | Jan 2015 | B2 |
8940011 | Teoh et al. | Jan 2015 | B2 |
8974509 | Licata | Mar 2015 | B2 |
8974513 | Ford et al. | Mar 2015 | B2 |
8992563 | Chen | Mar 2015 | B2 |
8998926 | Pomeranz | Apr 2015 | B2 |
9039749 | Shrivastava et al. | May 2015 | B2 |
9050095 | Monstadt et al. | Jun 2015 | B2 |
9055948 | Jaeqer et al. | Jun 2015 | B2 |
9211202 | Strother et al. | Dec 2015 | B2 |
9486224 | Riina et al. | Nov 2016 | B2 |
9833309 | Levi et al. | Dec 2017 | B2 |
9844380 | Furey | Dec 2017 | B2 |
9907684 | Connor et al. | Mar 2018 | B2 |
9962146 | Hebert et al. | May 2018 | B2 |
10028745 | Morsi | Jul 2018 | B2 |
20010000797 | Mazzocchi | May 2001 | A1 |
20010001835 | Greene et al. | May 2001 | A1 |
20020151883 | Guqlielmi | Oct 2002 | A1 |
20020151927 | Douk | Oct 2002 | A1 |
20030014073 | Bashiri et al. | Jan 2003 | A1 |
20030018294 | Cox | Jan 2003 | A1 |
20030028209 | Teoh et al. | Feb 2003 | A1 |
20030040733 | Cragg et al. | Feb 2003 | A1 |
20030040772 | Hyodoh et al. | Feb 2003 | A1 |
20030060833 | Carrison et al. | Mar 2003 | A1 |
20030176857 | Lee | Sep 2003 | A1 |
20030181927 | Wallace | Sep 2003 | A1 |
20030212426 | Olson et al. | Nov 2003 | A1 |
20030225365 | Greff et al. | Dec 2003 | A1 |
20040002731 | Aqanon et al. | Jan 2004 | A1 |
20040002733 | Teoh | Jan 2004 | A1 |
20040225279 | Ravmond | Nov 2004 | A1 |
20040236344 | Monstadt et al. | Nov 2004 | A1 |
20050079196 | Henkes et al. | Apr 2005 | A1 |
20050267511 | Marks et al. | Dec 2005 | A1 |
20060036281 | Patterson et al. | Feb 2006 | A1 |
20060100602 | Klint | May 2006 | A1 |
20060135986 | Wallace et al. | Jun 2006 | A1 |
20060155323 | Porter et al. | Jul 2006 | A1 |
20060200234 | Hines | Sep 2006 | A1 |
20060206199 | Churchwell et al. | Sep 2006 | A1 |
20060271097 | Ramzipoor et al. | Nov 2006 | A1 |
20070073334 | Ramzipoor | Mar 2007 | A1 |
20070100426 | Rudakov et al. | May 2007 | A1 |
20070175536 | Monetti et al. | Aug 2007 | A1 |
20070191924 | Rudakov | Aug 2007 | A1 |
20080045922 | Cragg et al. | Feb 2008 | A1 |
20080051803 | Monjtadt et al. | Feb 2008 | A1 |
20080103585 | Monstadt et al. | May 2008 | A1 |
20080125855 | Henkes et al. | May 2008 | A1 |
20080221666 | Licata et al. | Sep 2008 | A1 |
20080228215 | Strauss et al. | Sep 2008 | A1 |
20080228216 | Strauss et al. | Sep 2008 | A1 |
20080319532 | Monstadt et al. | Dec 2008 | A1 |
20090143786 | Bashiri et al. | Jun 2009 | A1 |
20090227976 | Calabria | Sep 2009 | A1 |
20090254111 | Monstadt et al. | Oct 2009 | A1 |
20100023105 | Levv et al. | Jan 2010 | A1 |
20100030200 | Strauss et al. | Feb 2010 | A1 |
20100049165 | Sutherland et al. | Feb 2010 | A1 |
20100063572 | Teoh et al. | Mar 2010 | A1 |
20100076479 | Monstadt | Mar 2010 | A1 |
20100144895 | Porter | Jun 2010 | A1 |
20100256666 | Chen et al. | Oct 2010 | A1 |
20100268204 | Tieu et al. | Oct 2010 | A1 |
20100331948 | Turovskiy et al. | Dec 2010 | A1 |
20110098814 | Monstadt et al. | Apr 2011 | A1 |
20110106128 | Chen | May 2011 | A1 |
20110118768 | Tran et al. | May 2011 | A1 |
20110118777 | Patterson et al. | May 2011 | A1 |
20110137405 | Wilson et al. | Jun 2011 | A1 |
20110184453 | Levy et al. | Jul 2011 | A1 |
20120010648 | Monstadt et al. | Jan 2012 | A1 |
20120209310 | Chen | Aug 2012 | A1 |
20120271344 | Ford et al. | Oct 2012 | A1 |
20120316632 | Gao | Dec 2012 | A1 |
20130138198 | Aporta et al. | May 2013 | A1 |
20130184743 | Chen et al. | Jul 2013 | A1 |
20130211492 | Schneider et al. | Aug 2013 | A1 |
20130274866 | Cox et al. | Oct 2013 | A1 |
20140005651 | Eskridqe | Jan 2014 | A1 |
20140012307 | Franano et al. | Jan 2014 | A1 |
20140039535 | Eskuri | Feb 2014 | A1 |
20140058420 | Hannes et al. | Feb 2014 | A1 |
20140135818 | Gandhi et al. | May 2014 | A1 |
20140142608 | Eskridge et al. | May 2014 | A1 |
20140148843 | Strauss et al. | May 2014 | A1 |
20140163604 | Monstadt | Jun 2014 | A1 |
20140236217 | Gandhi et al. | Aug 2014 | A1 |
20140277092 | Teoh et al. | Sep 2014 | A1 |
20140277094 | Chen et al. | Sep 2014 | A1 |
20140288633 | Burke et al. | Sep 2014 | A1 |
20140316012 | Freyman et al. | Oct 2014 | A1 |
20140371734 | Truckai | Dec 2014 | A1 |
20140371839 | Henkes et al. | Dec 2014 | A1 |
20150005804 | Franano et al. | Jan 2015 | A1 |
20150057700 | Chen et al. | Feb 2015 | A1 |
20150066073 | Ma | Mar 2015 | A1 |
20150105817 | Marchand et al. | Apr 2015 | A1 |
20150133990 | Davidson | May 2015 | A1 |
20150142042 | Cox | May 2015 | A1 |
20150150563 | Marchand et al. | Jun 2015 | A1 |
20150157331 | Levy et al. | Jun 2015 | A1 |
20150164665 | Cam et al. | Jun 2015 | A1 |
20150173771 | Marks et al. | Jun 2015 | A1 |
20150216684 | Enzmann et al. | Aug 2015 | A1 |
20150250628 | Monstadt et al. | Sep 2015 | A1 |
20150313737 | Tippett et al. | Nov 2015 | A1 |
20150327843 | Garrison | Nov 2015 | A1 |
20160066921 | Seifert et al. | Mar 2016 | A1 |
20160135984 | Rudakov et al. | May 2016 | A1 |
20160206320 | Connor | Jul 2016 | A1 |
20160206321 | Connor | Jul 2016 | A1 |
20170150971 | Hines | Jun 2017 | A1 |
20170156903 | Shobayashi | Jun 2017 | A1 |
20170189035 | Porter | Jul 2017 | A1 |
20170266023 | Thomas | Sep 2017 | A1 |
20170340333 | Badruddin et al. | Nov 2017 | A1 |
20170367708 | Mayer et al. | Dec 2017 | A1 |
20180028190 | Ozasa | Feb 2018 | A1 |
20180049859 | Stoppenhagen et al. | Feb 2018 | A1 |
20180125686 | Lu | May 2018 | A1 |
20180140305 | Connor | May 2018 | A1 |
20180161185 | Kresslein et al. | Jun 2018 | A1 |
20180193025 | Walzman | Jul 2018 | A1 |
20180193026 | Yang et al. | Jul 2018 | A1 |
20180206852 | Moeller | Jul 2018 | A1 |
20190053811 | Garza et al. | Feb 2019 | A1 |
Number | Date | Country |
---|---|---|
4445715 | Jun 1996 | DE |
1884208 | Feb 2008 | EP |
2668914 | Dec 2013 | EP |
2982316 | Feb 2016 | EP |
2004075736 | Sep 2004 | WO |
2011066962 | Jun 2011 | WO |
WO-2014078286 | May 2014 | WO |
2017074411 | May 2017 | WO |
2018051187 | Mar 2018 | WO |
Entry |
---|
International Search Report and Written Opinion dated Aug. 4, 2017, International Patent Application No. PCT/US2017/036699, 16 pages. |
Number | Date | Country | |
---|---|---|---|
20170367704 A1 | Dec 2017 | US |
Number | Date | Country | |
---|---|---|---|
62354968 | Jun 2016 | US |